Filing Flows › Aurinia Pharmaceuticals (AUPH) › Recalls, complaints & regulation
Aurinia Pharmaceuticals (AUPH): clinical trials
Aurinia Pharmaceuticals (AUPH) beyond its filings: 2 active clinical trials.
Aurinia Pharmaceuticals' latest quarter
Aurinia Pharmaceuticals, Q3 2026: revenue $83.7M (+14% year over year), operating margin 42.3%, net earnings $31.7M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Aurinia Pharmaceuticals have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.